Evolution of multi-drug resistant HCV clones from pre-existing resistant-associated variants during direct-acting antiviral therapy determined by third-generation sequencing

Resistance-associated variant (RAV) is one of the most significant clinical challenges in treating HCV-infected patients with direct-acting antivirals (DAAs). We investigated the viral dynamics in patients receiving DAAs using third-generation sequencing technology. Among 283 patients with genotype-...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Rep
Päätekijät: Takeda, Haruhiko, Ueda, Yoshihide, Inuzuka, Tadashi, Yamashita, Yukitaka, Osaki, Yukio, Nasu, Akihiro, Umeda, Makoto, Takemura, Ryo, Seno, Hiroshi, Sekine, Akihiro, Marusawa, Hiroyuki
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5374541/
https://ncbi.nlm.nih.gov/pubmed/28361915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep45605
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia